Notice of Intent to Sole Source – Mobility Research Inc.

To meet the mission of clinical patient care, the scientific research mission, standards for patient safety at the Mark O. Hatfield Clinical Research Center, (CRC), the Physical therapy Section in the Rehabilitation Medicine Department (RMD) requires the replacement of the current LiteGait mobility device. • Product Service Code: 6515 – Medical Instruments, Equipment, and Supplies • NAICS Code: 423450 – Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers • Place of Performance: Bethesda, MD 20892 USA POTS: 25-005340 Description: This is a notice of intent, not a request for a quotation. A solicitation document will not be issued and quotations will not be requested. The National Institutes of Health (NIH) intends to award a fixed price purchase order to Mobility Research Inc, located at 3156 W Lewis Ave, Phoenix, AZ, on a firm fixed price sole source award basis to provide replacement of the current LiteGait mobility device at the Physical therapy Section in the Rehabilitation Medicine Department (RMD). Below is a description of the item(s): Description: LiteGait 500x Units: Each Qty: 1 Catalog #: LG500X Description: iHarness Set – Junior Metal Units: Each Qty: 1 Catalog #: 1642 HSJM The proposed vendor, Mobility Research, is the only company which manufactures the LiteGait and is FDA registered with CE certifications. This is an important citation in order to meet the research mission of the Mark O. Hatfield Clinical Research Center while maintaining standards of patient safety. This acquisition is being conducted using policies unique to the Federal Acquisition Regulation (FAR) Part 13 – Simplified Acquisition Procedures, Subpart 13.106-1(b)(1), For purchases not exceeding the simplified acquisition threshold (SAT), contracting officers may solicit from one source if the contracting officer determines that the circumstance of the contract action deem only one source reasonably available. Contracts awarded using FAR Part 13-Simplified Acquisition Procedures are exempt from the requirements of FAR Part 6-Competition Requirements. Interested parties may identify their interest and capabilities in response to this posting. The determination by the Government not to compete the proposed requirement based upon responses to this notice is solely within the discretion of the Government. Comments to this announcement, referencing this posting number, may be submitted to the NIH, Clinical Center, Office of Purchasing and Contracts, prior to the closing date specified in this announcement, to the attention of Kristin Nagashima, Contract Specialist via email to [email protected] by May 9, 2025 at 4pm EST.